Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000806592-23-000008
Filing Date
2023-01-11
Accepted
2023-01-11 16:02:55
Documents
94
Period of Report
2022-10-31

Document Format Files

Seq Description Document Type Size
1 SUNWIN STEVIA INTERNATIONAL, INC. - FORM 10-Q SEC FILING suwn-20221031.htm   iXBRL 10-Q 557104
2 SECTION 302 CERTIFICATE OF THE CHIEF EXECUTIVE OFFICER sunw_ex31z1.htm EX-31.1 7537
3 SECTION 302 CERTIFICATE OF CHIEF FINANCIAL OFFICER sunw_ex31z2.htm EX-31.2 7506
4 SECTION 906 CERTIFICATE OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER sunw_ex32z1.htm EX-32.1 5085
  Complete submission text file 0000806592-23-000008.txt   3383522

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT suwn-20221031_cal.xml EX-101.CAL 24819
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT suwn-20221031_def.xml EX-101.DEF 36542
7 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT suwn-20221031_lab.xml EX-101.LAB 201931
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT suwn-20221031_pre.xml EX-101.PRE 170253
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT suwn-20221031.xsd EX-101.SCH 63508
88 EXTRACTED XBRL INSTANCE DOCUMENT suwn-20221031_htm.xml XML 411892
Mailing Address 6 SHENGWANG AVENUE, QUFU, SHANDONG F4 273100
Business Address 6 SHENGWANG AVENUE, QUFU, SHANDONG F4 273100 (86) 537-4424999
SUNWIN STEVIA INTERNATIONAL, INC. (Filer) CIK: 0000806592 (see all company filings)

EIN.: 562416925 | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 000-53595 | Film No.: 23523621
SIC: 2834 Pharmaceutical Preparations